News

Hikma buys rights to FDA-approved cancer treatment trametinib, a generic version of Novartis' (NVS) Mekinist, with 180 days ...
A three-judge panel wrestled Thursday with Novartis AG’s challenge against the FDA over its approval of a generic version of ...
Shares MSCI Switzerland ETF's high allocation to Nestle, Roche, and Novartis poses diversification risks. Read why EWL is a ...
European drugmaker Novartis (NVS), best known for blockbuster drugs like Entresto, Cosentyx, and Kesimpta, just announced a major U.S.
New Housing Price Index (March) The national index edged up 0.1% on a month-over-month basis in February, following a decline in the previous month. Cargojet Inc. (T.CJT) (Q1) EPS of $1.09 compared to ...
Factors driving the market include rising disease prevalence, innovative therapies, and gene-based treatment breakthroughs. Key players like H Lundbe ...
The pharmaceutical company will build six new production sites and one for research and development in the USA. This will ...
The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...
The Global Active Pharmaceutical Ingredients Market achieved a valuation of $209.80 Billion in 2024 and is anticipated to ...
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
Here are seven of the best Europe ETFs to buy in 2025: ...